I forgot to mention CERC I will still keep an ey
Post# of 658
moved well on Friday but opened on gap
Prev Close 3.35 Open 4.39
with high volume
Volume 1,272,508
Avg Vol (3m) 74,004
IMO to watch out the 4.25 and 4.52 if it break over 5+ sup 4.06 then 3.82 but do your DD
Quote:
Riding on the coattails of Alkermes’s positive phase 3 data of ALKS 5461 is Cerecor Inc (NASDAQ:CERC), which is 56% higher thanks to the company’s lead product candidate, CERC-301, also being a potential treatment of major depressive disorder. CERC-301 is a NR2B specific NMDA antagonist and is currently in phase 2 trials, while Alkermes’ ALKS 5461 is a Mu receptor partial agonist/kappa receptor antagonist. Of the 749 hedge funds that we track which filed 13Fs for the June quarter, three owned a total of $722,000 worth of Cerecor Inc (NASDAQ:CERC) shares on June 30.
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone